Skip to main content

Table 1 Clinical characteristics of study subjects

From: Circulating survivin levels in healthy and asthmatic pregnancy

  AP N = 28 ANP N = 25 HP N = 21 HNP N = 29 P value
FEV 1 ; L 2.9 ± 0.4 2.8 ± 0.7 ND ND 0.54
(% pred) (90 ± 11) (88 ± 18) (0.66)
FVC; L 3.6 ± 0.5 3.7 ± 0.8 ND ND 0.85
(% pred) (99 ± 13) (100 ± 15) (0.68)
FE NO ; ppb 19 (8–115) 19 (5–82) ND ND 0.62
ACT 20 (8–25) 20 (9–25) ND ND 0.76
ICS; BDP eq. 200 (0–2000) 400 (0–1000) NA NA 0.25
Neonatal birth weight; g 3548 ± 714 NA 3442 ± 320 NA 0.59
Apgar; 1 and 5 minutes 9 and 10 NA 9 and 10 NA 0.27 and 0.95
Week of delivery 39 (36–42) NA 39 (36–41) NA 0.44
  1. AP: asthmatic pregnant, ANP: asthmatic non-pregnant, HP: healthy pregnant, HNP: healthy non-pregnant, ACT: asthma control test, BDP eq.: beclomethasone dipropionate equivalent, FENO: fractional exhaled nitric oxide, FEV1: forced expiratory volume in one second, FVC: forced vital capacity, ICS: inhaled corticosteroid, NA: not applicable, ND: not determined, ppb: particles per billion. Data are expressed as mean ± SD or median (range).